Lab investigations, Radiology, Endoscopic, Cardio-vascular, neurological, Genetic& molecular, functional or ogran specific investigation
LFT (Liver Function test) test – Disease
π¬ Liver Function Tests (LFTs) in Different Liver Diseases
Liver function tests (LFTs) are used to assess hepatocellular integrity, biliary excretion, and synthetic capacity. These tests help differentiate between various liver diseases such as hepatitis, cirrhosis, cholestasis, fatty liver, and drug-induced liver injury.
πΉ 1. Overview of Liver Function Tests
Test
Normal Range
Function
ALT (Alanine Aminotransferase)
7 – 55 U/L
Hepatocellular injury
AST (Aspartate Aminotransferase)
10 – 40 U/L
Hepatocellular injury (also in muscle)
ALP (Alkaline Phosphatase)
44 – 147 U/L
Biliary tract function
GGT (Gamma-Glutamyl Transferase)
9 – 48 U/L
Alcoholic liver disease & cholestasis
Total Bilirubin
0.2 – 1.2 mg/dL
Breakdown of hemoglobin
Direct (Conjugated) Bilirubin
0.1 – 0.4 mg/dL
Excreted via bile
Albumin
3.5 – 5.5 g/dL
Liver’s protein synthesis
Prothrombin Time (PT/INR)
INR < 1.2
Liverβs coagulation ability
πΉ 2. LFT Patterns in Different Liver Diseases
1οΈβ£ Viral Hepatitis (Hepatitis A, B, C, D, E)
Test
Expected Change
ALT & AST
ββ (>1000 U/L) (Acute phase)
Bilirubin
β (Moderate)
ALP
Normal or Mild β
GGT
Normal or Mild β
Albumin
Normal (Acute) / β (Chronic)
PT/INR
Normal or Mild β
π Key Feature: Very high ALT/AST, often ALT > AST, especially in acute viral hepatitis.
2οΈβ£ Alcoholic Liver Disease (ALD)
Test
Expected Change
ALT & AST
β (AST:ALT > 2:1 ratio)
Bilirubin
β (in severe cases)
ALP
Mild β
GGT
ββ (Alcohol-specific marker)
Albumin
β (Chronic cases)
PT/INR
β (Severe cases)
π Key Feature:AST:ALT > 2:1 with significantly elevated GGT.
3οΈβ£ Non-Alcoholic Fatty Liver Disease (NAFLD)
Test
Expected Change
ALT & AST
Mild β (ALT > AST)
Bilirubin
Normal
ALP
Normal or Mild β
GGT
Mild β
Albumin
Normal
PT/INR
Normal
π Key Feature: Mildly elevated ALT with normal ALP & Bilirubin, associated with obesity, diabetes, and metabolic syndrome.
4οΈβ£ Cirrhosis (End-Stage Liver Disease)
Test
Expected Change
ALT & AST
Normal or Mild β
Bilirubin
ββ (Severe cases)
ALP
β
GGT
β
Albumin
ββ (Liver failure)
PT/INR
ββ (Poor prognosis)
π Key Feature:Low albumin, prolonged PT/INR, and high bilirubin indicate decompensated cirrhosis.